US Patent Issued to VisCardia on July 15 for "Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health" (Oregon Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,825, issued on July 15, was assigned to VisCardia Inc. (Beaverton, Ore.).

"Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health" was invented by Peter T. Bauer (Portland, Ore.) and Timothy Wheeler (Portland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Devices, systems and methods provide forms of asymptomatic diaphragmatic stimulation (ADS) therapy that affect pressures within the intrathoracic cavity, including: 1) dual-pulse ADS therapy, during which a first ADS pulse is delivered during a diastolic phase of a cardiac cycle and a second ADS p...